Epidermal growth factor enhances guanylate cyclase activity in vivo and in vitro

• Published in: Endocrinology (Philadelphia) Vol. 116; no. 1; p. 332
• Main Authors: Scheving, L A, Scheving, L E, Tsai, T H, Vesely, D L
• Format: Journal Article
• Language: English
• Published: United States 01.01.1985
• Subjects: Animals; Cecum - enzymology; Cyclic GMP - biosynthesis; Dose-Response Relationship, Drug; Enzyme Activation; Epidermal Growth Factor - pharmacology; Guanylate Cyclase - metabolism; Hypophysectomy; Kidney - enzymology; Liver - enzymology; Male; Mice
• ISSN: 0013-7227
• DOI: 10.1210/endo-116-1-332

Epidermal growth factor (EGF) increases DNA synthesis and cell division both in vivo and in vitro. The mechanism by which EGF increases growth and DNA synthesis is unknown. Since the intracellular messenger cGMP stimulates DNA synthesis, the present investigation was designed to determine if EGF might have part of its mechanism of action through activating guanylate cyclase [EC 4.6.1.2], the enzyme that catalyzes the formation of cGMP. EGF enhanced soluble and particulate guanylate cyclase activities as well as cGMP levels 2- to 3-fold in hypophysectomized and nonhypophysectomized tissues both in vivo and in vitro. EGF increased guanylate cyclase activity 0.5 h after ip injection in mice, and this increased activity was still present 12 h later. Guanylate cyclase activity was increased to a greater extent secondary to EGF in hypophysectomized cecum compared to nonhypophysectomized cecum. Dose-response curves revealed that maximal stimulation of guanylate cyclase by EGF occurred at 1 nM. There was no augmented guanylate cyclase activity when the concentration of EGF was decreased to 0.01 nM. The data in this investigation suggest that guanylate cyclase may play a role in the mechanism of action of EGF.